FDA Approves Qelbree (Viloxazine), First New Children's ADHD Drug in 10 Years

TUESDAY, April 6, 2021 — The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration.
Qelbree, also known as viloxazine, comes in a…
Source: Topamax